文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Ly6C 单核细胞平衡调节性和细胞毒性 CD4 T 细胞应答,以控制病毒诱导的免疫病理学。

Ly6C monocytes balance regulatory and cytotoxic CD4 T cell responses to control virus-induced immunopathology.

机构信息

Laboratory of Immunology and Vaccinology, Faculty of Veterinary Medicine, FARAH, ULiège, Liège 4000, Belgium.

Laboratory of Biology of Tumor and Development, GIGA-Cancer ULiège and "Centre Hospitalier Universitaire de Liège (CHU)", Liège 4000, Belgium.

出版信息

Sci Immunol. 2022 Jul 15;7(73):eabn3240. doi: 10.1126/sciimmunol.abn3240.


DOI:10.1126/sciimmunol.abn3240
PMID:35857578
Abstract

Gammaherpesviruses (γHVs) have coevolved with their host, leading to a remarkably high infection prevalence and establishment of latency. The lifelong persistence of γHVs in hosts appears to broadly shape host immunity, and we show here that pulmonary infection with Murid herpesvirus 4 (MuHV-4), a mouse γHV, drives the recruitment of Ly6C monocytes (MOs) into the airway, thereby modulating the host immune response. The absence of Ly6C MOs is associated with severe virus-induced immunopathology and the systemic release of inflammatory mediators. Mechanistically, MuHV-4-imprinted MOs recruit CD4 T cells to the airways and trigger immunosuppressive signaling pathways through the PD-L1/PD-1 axis, thereby dampening the deleterious activation of cytotoxic CD4 T cells. These results uncover a role for Ly6C MOs in modulating CD4 T cell functions and reveal pathways that could be targeted therapeutically to reduce detrimental immunopathological responses associated with respiratory viral infections.

摘要

γ 疱疹病毒(γHVs)与宿主共同进化,导致其感染率极高且潜伏期长。γHVs 在宿主体内的终身存在似乎广泛影响宿主的免疫功能,我们在这里表明,肺部感染鼠疱疹病毒 4(MuHV-4),一种小鼠 γHV,会促使 Ly6C 单核细胞(MOs)招募到气道中,从而调节宿主的免疫反应。缺乏 Ly6C MOs 与严重的病毒诱导免疫病理学和炎症介质的全身释放有关。从机制上讲,MuHV-4 印记的 MOs 通过 PD-L1/PD-1 轴将 CD4 T 细胞招募到气道,并触发免疫抑制信号通路,从而抑制细胞毒性 CD4 T 细胞的有害激活。这些结果揭示了 Ly6C MOs 在调节 CD4 T 细胞功能中的作用,并揭示了可以通过靶向治疗来减轻与呼吸道病毒感染相关的有害免疫病理反应的途径。

相似文献

[1]
Ly6C monocytes balance regulatory and cytotoxic CD4 T cell responses to control virus-induced immunopathology.

Sci Immunol. 2022-7-15

[2]
Ly6C monocytes regulate T cell responses in viral hepatitis.

JCI Insight. 2016-10-20

[3]
Interferon-γ-Producing CD4 T Cells Drive Monocyte Activation in the Bone Marrow During Experimental Infection.

Front Immunol. 2021

[4]
Dampening type 2 properties of group 2 innate lymphoid cells by a gammaherpesvirus infection reprograms alveolar macrophages.

Sci Immunol. 2023-2-24

[5]
Immunosuppressive CD11b+Ly6Chi monocytes in pristane-induced lupus mouse model.

J Leukoc Biol. 2016-6

[6]
Programmed Cell Death Ligand (PD-L)-1 Contributes to the Regulation of CD4 T Effector and Regulatory T Cells in Cutaneous Leishmaniasis.

Front Immunol. 2020

[7]
IL-27 Negatively Regulates Tip-DC Development during Infection.

mBio. 2021-2-16

[8]
BAFF receptor deficiency limits gammaherpesvirus infection.

J Virol. 2014-2-5

[9]
Ly6C inflammatory monocytes promote susceptibility to Leishmania donovani infection.

Sci Rep. 2017-10-31

[10]
NFAT1 Regulates Ly6C Monocyte Recruitment to the CNS and Plays an Essential Role in Resistance to Infection.

Front Immunol. 2019-9-6

引用本文的文献

[1]
Brucella abortus impairs T lymphocyte responsiveness by mobilizing IL-1RA-secreting omental neutrophils.

Nat Commun. 2025-1-20

[2]
Vascular endothelial-derived SPARCL1 exacerbates viral pneumonia through pro-inflammatory macrophage activation.

Nat Commun. 2024-5-18

[3]
Functional Phenotyping of Lung Mouse CD4 T Cells Using Multiparametric Flow Cytometry Analysis.

Bio Protoc. 2023-9-20

[4]
Shaping of the alveolar landscape by respiratory infections and long-term consequences for lung immunity.

Front Immunol. 2023

[5]
Interferon gamma-1b for the prevention of hospital-acquired pneumonia in critically ill patients: a phase 2, placebo-controlled randomized clinical trial.

Intensive Care Med. 2023-5

[6]
The innate immune brakes of the lung.

Front Immunol. 2023

[7]
Erratum: Type 1 regulatory T cell-mediated tolerance in health and disease.

Front Immunol. 2022

[8]
Type 1 regulatory T cell-mediated tolerance in health and disease.

Front Immunol. 2022

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索